Back to search

France· FR:67588742

SCYOVA 240 mg/mL + 12 mg/mL, solution pour perfusion

A medicinal product containing foslévodopa + foscarbidopa, registered in France by ABBVIE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSCYOVA 240 mg/mL + 12 mg/mL, solution…ATC—REGISTER NO.FR:67588742PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FOSLÉVODOPA + FOSCARBIDOPA
Manufacturer
ABBVIE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930279083
    7 flacons en verre de 10 mL
    EUR 519.34

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Foslévodopa + foscarbidopa in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All foslévodopa + foscarbidopa products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Produodopa
  • Belgium · Produodopa
  • Bulgaria · Продуодопа
  • Cyprus · Produodopa
  • Czechia · Duodopa Sc
  • Germany · Produodopa®
  • Denmark · Duodopa
  • Estonia · Produodopa
  • Spain · Duodopa
  • Finland · Produodopa
  • Greece · Produodopa
  • Croatia · Produodopa
  • Hungary · Produodopa
  • Ireland · Produodopa
  • Iceland · Produodopa
  • Italy · Duodopa
  • Liechtenstein · Produodopa
  • Lithuania · Duodopa
  • Luxembourg · Produodopa
  • Netherlands · Duodopa
  • Norway · Produodopa
  • Poland · Produodopa
  • Portugal · Duodopa
  • Romania · Produodopa
  • Sweden · Produodopa
  • Slovenia · Produodopa
  • Slovakia · Duodopa Sc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1ad34407-f727-4cd8-931f-e7335375d022
GET /v1/drugs/1ad34407-f727-4cd8-931f-e7335375d022?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67588742",
  "date_amm": "2023-09-01",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "FOSLÉVODOPA + FOSCARBIDOPA",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution pour perfusion",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about foslévodopa + foscarbidopa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.